A call to limit antibiotic use in acne

Journal of Drugs in Dermatology

Volumn 12, Issue 12, 2013, Pages 1331-

  Thiboutot, Diane ^a   Dreno, Brigitte ^b   Gollnick, Harald ^c   Bettoli, Vincenzo ^d   Kang, Sewon ^e   Leyden, James J ^f   Shalita, Alan ^g   Torres, Vicente ^h  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITÉ DE NANTES   (France)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

^d UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g SUNY Downstate Medical Center   (United States)

^h Juarez Hospital   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ACNE; ANTIBIOTIC THERAPY; DRUG UTILIZATION; EDITORIAL; HUMAN; NONHUMAN; PRESCRIPTION; PROPIONIBACTERIUM ACNES;

ACNE VULGARIS; ANTI-BACTERIAL AGENTS; DERMATOLOGY; DRUG RESISTANCE, BACTERIAL; HUMANS; PHYSICIAN'S PRACTICE PATTERNS;

EID: 84890935940     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (31)

1. G8 ministers pledge to act on bacterial antibiotic resistance. Financial Times 2013;June 13.
2. Jenkins TC, Irwin A, Coombs L, Dealleaume L, Ross SE, Rozwadowski J et al. Effects of clinical pathways for common outpatient infections on antibiotic prescribing. The American journal of medicine 2013;126:327-35 e12.
3. Narahari S, Gustafson CJ, Feldman SR. What's new in antibiotics in the management of acne? Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia 2012;147:227-38.
4. Kinney MA, Yentzer BA, Fleischer AB, Jr., Feldman SR. Trends in the treatment of acne vulgaris: are measures being taken to avoid antimicrobial resistance? Journal of drugs in dermatology : JDD 2010;9:519-24.
5. Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. Journal of the American Academy of Dermatology 2003;49:S1-37.
6. Thiboutot D, Gollnick H, Bettoli V, Dreno B, Kang S, Leyden JJ et al. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. Journal of the American Academy of Dermatology 2009;60:S1-50.
7. Cooper AJ. Systematic review of Propionibacterium acnes resistance to systemic antibiotics. The Medical journal of Australia 1998;169:259-61.
8. Mills O, Jr., Thornsberry C, Cardin CW, Smiles KA, Leyden JJ. Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicle. Acta dermato-venereologica 2002;82:260-5.
9. Luk NM, Hui M, Lee HC, Fu LH, Liu ZH, Lam LY et al. Antibiotic-resistant Propionibacterium acnes among acne patients in a regional skin centre in Hong Kong. Journal of the European Academy of Dermatology and Venereology : JEADV 2013;27:31-6.
10. Abdel Fattah NS, Darwish YW. In vitro antibiotic susceptibility patterns of Propionibacterium acnes isolated from acne patients: an Egyptian university hospital-based study. Journal of the European Academy of Dermatology and Venereology : JEADV 2012.
11. Leyden JJ, Del Rosso JQ. Oral antibiotic therapy for acne vulgaris: pharmacokinetic and pharmacodynamic perspectives. The Journal of clinical and aesthetic dermatology 2011;4:40-7.
12. Schafer F, Fich F, Lam M, Garate C, Wozniak A, Garcia P. Antimicrobial susceptibility and genetic characteristics of Propionibacterium acnes isolated from patients with acne. International journal of dermatology 2013;52:418-25.
13. Tzellos T, Zampeli V, Makrantonaki E, Zouboulis CC. Treating acne with antibiotic-resistant bacterial colonization. Expert opinion on pharmacotherapy 2011;12:1233-47.
14. Leyden JJ, McGinley KJ, Cavalieri S, Webster GF, Mills OH, Kligman AM. Propionibacterium acnes resistance to antibiotics in acne patients. Journal of the American Academy of Dermatology 1983;8:41-5.
15. Ozolins M, Eady EA, Avery AJ, Cunliffe WJ, Po AL, O'Neill C et al. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. Lancet 2004;364:2188-95.
16. Levy RM, Huang EY, Roling D, Leyden JJ, Margolis DJ. Effect of antibiotics on the oropharyngeal flora in patients with acne. Arch Dermatol 2003;139:467-71.
17. Nord CE, Oprica C. Antibiotic resistance in Propionibacterium acnes. Microbiological and clinical aspects. Anaerobe 2006;12:207-10.
18. Ross JI, Eady EA, Carnegie E, Cove JH. Detection of transposon Tn5432-mediated macrolide-lincosamide- streptogramin B (MLSB) resistance in cutaneous propionibacteria from six European cities.The Journal of antimicrobial chemotherapy 2002;49:165-8.
19. Ross JI, Eady EA, Cove JH, Cunliffe WJ. 16S rRNA mutation associated with tetracycline resistance in a gram-positive bacterium. Antimicrobial agents and chemotherapy 1998;42:1702-5.
20. Leyden JJ. The evolving role of Propionibacterium acnes in acne. Seminars in cutaneous medicine and surgery 2001;20:139-43.
21. Leyden JJ, McGinley KJ, Mills OH, Kligman AM. Propionibacterium levels in patients with and without acne vulgaris. The Journal of investigative dermatology 1975;65:382-4.
22. Skidmore R, Kovach R, Walker C, Thomas J, Bradshaw M, Leyden J et al. Effects of subantimicrobialdose doxycycline in the treatment of moderate acne. Archives of dermatology 2003;139:459-64.
23. Toossi P, Farshchian M, Malekzad F, Mohtasham N, Kimyai-Asadi A. Subantimicrobial-dose doxycycline in the treatment of moderate facial acne. Journal of drugs in dermatology : JDD 2008;7:1149-52.
24. Plewig GK, A. Acne and Rosacea. New York: Springer; 2000.
25. Seidler EM, Kimball AB. Meta-analysis comparing efficacy of benzoyl peroxide, clindamycin, benzoyl peroxide with salicylic acid, and combination benzoyl peroxide/clindamycin in acne. Journal of the American Academy of Dermatology 2010;63:52-62.
26. Del Rosso JQ, Kim GK. Topical antibiotics: therapeutic value or ecologic mischief? Dermatologic therapy 2009;22:398-406.
27. Kircik L. Rapid and efficacious fixed-combination monotherapy: desired results for the patient and improved adherence for the clinician. Cutis; cutaneous medicine for the practitioner 2009;84:5-11.
28. Lookingbill DP, Chalker DK, Lindholm JS, Katz HI, Kempers SE, Huerter CJ et al. Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations. Journal of the American Academy of Dermatology 1997;37:590-5.
29. Nast A, Dreno B, Bettoli V, Degitz K, Erdmann R, Finlay AY et al. European evidence-based (S3) guidelines for the treatment of acne. Journal of the European Academy of Dermatology and Venereology : JEADV 2012;26 Suppl 1:1-29.
30. Monk E, Shalita A, Siegel DM. Clinical applications of non-antimicrobial tetracyclines in dermatology. Pharmacological research : the official journal of the Italian Pharmacological Society 2011;63:130-45.
31. Simonart T, Dramaix M. Treatment of acne with topical antibiotics: lessons from clinical studies. The British journal of dermatology 2005;153:395-403.